232 related articles for article (PubMed ID: 20356832)
21. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
22. Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum.
Campana V; Sarnataro D; Fasano C; Casanova P; Paladino S; Zurzolo C
J Cell Sci; 2006 Feb; 119(Pt 3):433-42. PubMed ID: 16443748
[TBL] [Abstract][Full Text] [Related]
23. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
24. Prion infection: seeded fibrillization or more?
Birkmann E; Riesner D
Prion; 2008; 2(2):67-72. PubMed ID: 19098436
[TBL] [Abstract][Full Text] [Related]
25. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
26. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
27. A Quick Method to Evaluate the Effect of the Amino Acid Sequence in the Misfolding Proneness of the Prion Protein.
Fernández-Borges N; Eraña H; Elezgarai SR; Harrathi C; Venegas V; Castilla J
Methods Mol Biol; 2017; 1658():205-216. PubMed ID: 28861792
[TBL] [Abstract][Full Text] [Related]
28. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
29. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
31. Copper binding to the octarepeats of the prion protein. Affinity, specificity, folding, and cooperativity: insights from circular dichroism.
Garnett AP; Viles JH
J Biol Chem; 2003 Feb; 278(9):6795-802. PubMed ID: 12454014
[TBL] [Abstract][Full Text] [Related]
32. Immunological mimicry of PrPC-PrPSc interactions: antibody-induced PrP misfolding.
Li L; Guest W; Huang A; Plotkin SS; Cashman NR
Protein Eng Des Sel; 2009 Aug; 22(8):523-9. PubMed ID: 19602568
[TBL] [Abstract][Full Text] [Related]
33. Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins.
Maas E; Geissen M; Groschup MH; Rost R; Onodera T; Schätzl H; Vorberg IM
J Biol Chem; 2007 Jun; 282(26):18702-10. PubMed ID: 17468101
[TBL] [Abstract][Full Text] [Related]
34. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
Miller MB; Geoghegan JC; Supattapone S
PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
[TBL] [Abstract][Full Text] [Related]
35. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
[TBL] [Abstract][Full Text] [Related]
36. Cooperative binding of dominant-negative prion protein to kringle domains.
Ryou C; Prusiner SB; Legname G
J Mol Biol; 2003 May; 329(2):323-33. PubMed ID: 12758079
[TBL] [Abstract][Full Text] [Related]
37. Toward molecular dissection of PrPC-PrPSc interactions.
Solforosi L; Bellon A; Schaller M; Cruite JT; Abalos GC; Williamson RA
J Biol Chem; 2007 Mar; 282(10):7465-71. PubMed ID: 17218310
[TBL] [Abstract][Full Text] [Related]
38. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
Norstrom EM; Mastrianni JA
J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
[TBL] [Abstract][Full Text] [Related]
39. Characterization of conformation-dependent prion protein epitopes.
Kang HE; Weng CC; Saijo E; Saylor V; Bian J; Kim S; Ramos L; Angers R; Langenfeld K; Khaychuk V; Calvi C; Bartz J; Hunter N; Telling GC
J Biol Chem; 2012 Oct; 287(44):37219-32. PubMed ID: 22948149
[TBL] [Abstract][Full Text] [Related]
40. The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrP
Pagadala NS; Bjorndahl TC; Joyce M; Wishart DS; Syed K; Landi A
Bioorg Med Chem; 2017 Oct; 25(20):5875-5888. PubMed ID: 28951092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
